Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice

scientific article

Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1096/FJ.08-108548
P3181OpenCitations bibliographic resource ID4002077
P932PMC publication ID2537432
P698PubMed publication ID18606865

P2093author name stringTao Wang
Jonathan A Epstein
Thomas Huebner
Anne Granger
Peter J Gruber
Ibrahim Abdullah
Andrea Stout
Faith Huebner
P2860cites workmHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activityQ22253463
Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5Q24290618
CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophyQ24293269
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alphaQ24308024
The language of covalent histone modificationsQ27860931
Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1Q28141355
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophyQ28219383
Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activityQ28274440
Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesisQ28505748
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activityQ28508698
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart developmentQ28592216
Acetylation: a regulatory modification to rival phosphorylation?Q29614886
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerQ29615649
Histone methylation in transcriptional controlQ29616553
Histone and chromatin cross-talkQ29617179
Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53.Q33853515
Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatinQ34188997
Histone acetylation and chromatin remodelingQ34219273
MRL mice fail to heal the heart in response to ischemia-reperfusion injury.Q34411234
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alphaQ34519869
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeQ34595917
Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neuronsQ35676840
Linking covalent histone modifications to epigenetics: the rigidity and plasticity of the marksQ36238549
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasisQ36322698
Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotoninQ36366651
Ischemic epigenetics and the transplanted kidneyQ38306439
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alphaQ40236336
Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification.Q40244153
Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarctionQ40643967
Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gelsQ40980631
Endothelin ET(B) receptor-mediated mechanisms involved in oleic acid-induced acute lung injury in miceQ42525135
Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signalingQ43873079
Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic miceQ44300932
Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytesQ44559477
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeQ45002081
Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytesQ45108317
Pathophysiological consequences of VEGF-induced vascular permeabilityQ46349878
Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injuryQ46990138
Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins.Q48010453
Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action.Q48235397
Effects of cerebral ischemia in mice lacking DNA methyltransferase 1 in post-mitotic neuronsQ48701586
DNA methyltransferase contributes to delayed ischemic brain injury.Q52972663
Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumorsQ78101810
Inhibition of histone deacetylase on ventricular remodeling in infarcted ratsQ80076073
Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesisQ80182843
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectreperfusion injuryQ1413991
P304page(s)3549-60
P577publication date2008-10-01
P1433published inFASEB JournalQ520194
P1476titleHistone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice
P478volume22